Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Ann Hepatol ; 8(4): 353-8, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-20009135

RESUMEN

INTRODUCTION: Hepatitis A virus can evolve to acute liver failure with a fatal outcome if it is not reversed. OBJECTIVE: We describe the clinical course of 12 children who presented with hepatitis A acute liver failure and received treatment with oral N-acetylcysteine (NAC). MATERIALS AND METHODS: Of the seventy-two patients with viral hepatitis A, 12 patients who had acute hepatic failure were included. The variables evaluated were age, sex, duration of clinical features prior to hospitalization, signs and symptoms, laboratory parameters [alanine aminotransferase (ALT), aspartate aminotransferase (AST), prothrombin time (PT), partial thromboplastin time (PTT), internal normalization ratio and ammonia], treatment (oral NAC 100 mg/kg/day, lactulose, neomycin and general measures) and clinical course during hospitalization. RESULTS: Six males and six females were included. School-aged and adolescent children predominated. All presented with jaundice, nausea, vomiting and hepatomegaly. Two had stage 2 neurological signs as per the West-Haven scale. All had altered laboratory parameters. All received NAC, six patients for a week and the remaining six for 9-36 days. Treatment was not ceased until patients showed clinical and laboratory improvement. All data were analyzed using both student's t test and Wilcoxon signed rank with alpha = 0.05, the ALT with P = 0.0003 and 0.005, AST with P = 0.0001 and 0.0005, PT with P = 0.0237 and 0.0005, PTT with P = 0.0515 and 0.0039, ammonia with P = 0.0197 and 0.0015 and direct bilirubin with P = 0.0190 and 0.068. There was good tolerance to medications and a satisfactory clinical course. DISCUSSION: The use of oral NAC appears to be an effective therapeutic alternative for hepatitis A-induced liver failure if it is offered appropriately. It can modify the clinical course to a favorable one and prevent the fatal outcome of hepatic encephalopathy.


Asunto(s)
Acetilcisteína/uso terapéutico , Antivirales/uso terapéutico , Hepatitis A/complicaciones , Hepatitis A/tratamiento farmacológico , Fallo Hepático Agudo/tratamiento farmacológico , Fallo Hepático Agudo/etiología , Acetilcisteína/administración & dosificación , Administración Oral , Adolescente , Alanina Transaminasa/sangre , Antibacterianos/uso terapéutico , Antivirales/administración & dosificación , Aspartato Aminotransferasas/sangre , Niño , Quimioterapia Combinada , Femenino , Fármacos Gastrointestinales/uso terapéutico , Hepatitis A/sangre , Humanos , Lactulosa/uso terapéutico , Fallo Hepático Agudo/sangre , Masculino , México , Neomicina/uso terapéutico , Tiempo de Protrombina , Estudios Retrospectivos , Resultado del Tratamiento
2.
Pediatr Infect Dis J ; 37(5): e136-e138, 2018 05.
Artículo en Inglés | MEDLINE | ID: mdl-28858043

RESUMEN

The aim of this study was to identify the clinical manifestations of cryptosporidiosis and the distribution of Cryptosporidium spp. and subtypes in children in Sonora, Mexico. Two subtypes of C. parvum, including IIaA15G2R1 and IIcA5G3a, and 6 subtypes of Cryptosporidium hominis, including IaA14R3, IaA15R3, IbA12G3, IdA23, IeA11G3T3, and a new subtype IaA14R11, were identified. Cryptosporidium as an etiologic agent for acute gastroenteritis is discussed.


Asunto(s)
Criptosporidiosis/epidemiología , Cryptosporidium/aislamiento & purificación , Enfermedad Aguda/epidemiología , Niño , Preescolar , Cryptosporidium/genética , ADN Protozoario , Heces/parasitología , Femenino , Gastroenteritis/parasitología , Genotipo , Humanos , Lactante , Masculino , México/epidemiología , Reacción en Cadena de la Polimerasa , Análisis de Secuencia de ADN
3.
Pediatr Infect Dis J ; 35(11): 1265-1266, 2016 11.
Artículo en Inglés | MEDLINE | ID: mdl-27341498

RESUMEN

Cryptosporidium canis is reported for the first time in 2 toddlers in Northwestern Mexico. The 2 toddlers (33 and 34 months old) were symptomatic at diagnosis, presenting diarrhea and fever, and 1 case presented chronic malnutrition. Both toddlers were HIV-negative. C. canis was identified by SspI and VspI restriction enzyme digestion of the 18S rRNA polymerase chain reaction products and confirmed by sequence analysis.


Asunto(s)
Criptosporidiosis , Antiprotozoarios , Preescolar , Criptosporidiosis/diagnóstico , Criptosporidiosis/tratamiento farmacológico , Criptosporidiosis/parasitología , Cryptosporidium/genética , Cryptosporidium/aislamiento & purificación , ADN Protozoario/genética , Diarrea , Fiebre , Genotipo , Humanos , México
4.
Infect Genet Evol ; 44: 334-340, 2016 10.
Artículo en Inglés | MEDLINE | ID: mdl-27476606

RESUMEN

Blastocystis sp. is an anaerobic intestinal microorganism commonly identified in the feces of several animals, including humans. Blastocystis exhibits high genetic polymorphism and at least 17 subtypes (ST) have been identified; ST1-ST3 are frequently found in the Americas. Furthermore, in vitro assays have shown that temperature and humidity can affect the viability of Blastocystis cysts. In this study, we describe the genetic variability and genetic differentiation among and within Blastocystis STs in adults and children from the cities of Hermosillo and Morelia cities, which represent arid and humid subtropical climatic regions of México, respectively. Phylogenetic and genetic diversity was assessed by analyzing a region of the small subunit ribosomal DNA (SSU rDNA) gene as a marker. Blastocystis ST3 and ST1 were associated with children from Hermosillo and Morelia, respectively. An analysis of the nucleotide diversity (π) and haplotype polymorphism (θ) indexes showed that they were similar within each ST, but different between ST1 and ST3. Interestingly, the group of symptomatic carriers from Hermosillo showed scarce mean nucleotide diversity compared to the asymptomatic carriers (0.0039±0.0030 and 0.0329±0.0286, respectively). Furthermore, the gene flow and genetic differentiation indexes between the children and adults suggested that the Blastocystis haplotypes in the adult carriers were "highly mobile" among humans, while the haplotypes found in the children were more isolated and genetically differentiated between them.


Asunto(s)
Infecciones por Blastocystis/epidemiología , Infecciones por Blastocystis/parasitología , Blastocystis/clasificación , Blastocystis/genética , Portador Sano , Clima , Variación Genética , Genotipo , Adolescente , Adulto , Anciano , Niño , Preescolar , Femenino , Haplotipos , Humanos , Lactante , Masculino , México/epidemiología , Persona de Mediana Edad , Filogenia , Polimorfismo Genético , ARN Ribosómico/genética , Análisis de Secuencia de ADN , Adulto Joven
5.
PLoS One ; 9(4): e96128, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24755606

RESUMEN

Cryptosporidiosis is a parasitic disease caused by Cryptosporidium spp. In immunocompetent individuals, it usually causes an acute and self-limited diarrhea; in infants, infection with Cryptosporidium spp. can cause malnutrition and growth retardation, and declined cognitive ability. In this study, we described for the first time the distribution of C. parvum and C. hominis subtypes in 12 children in Mexico by sequence characterization of the 60-kDa glycoprotein (GP60) gene of Cryptosporidium. Altogether, 7 subtypes belonging to 4 subtype families of C. hominis (Ia, Ib, Id and Ie) and 1 subtype family of C. parvum (IIa) were detected, including IaA14R3, IaA15R3, IbA10G2, IdA17, IeA11G3T3, IIaA15G2R1 and IIaA16G1R1. The frequency of the subtype families and subtypes in the samples analyzed in this study differed from what was observed in other countries.


Asunto(s)
Criptosporidiosis/parasitología , Cryptosporidium/genética , Glicoproteínas/genética , Proteínas Protozoarias/genética , Adolescente , Niño , Preescolar , Cryptosporidium/clasificación , Heces/parasitología , Femenino , Genes Protozoarios , Humanos , Lactante , Masculino , México , Tipificación Molecular , Análisis de Secuencia de ADN
6.
Anticancer Res ; 30(10): 3903-10, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21036701

RESUMEN

E-Cadherin functions as a tumor suppressor in some invasive breast carcinomas and metastasis is promoted when its expression is lost. It has been observed, however, that in one of the most aggressive human breast cancers, inflammatory breast cancer (IBC), E-cadherin is overexpressed and this accounts for the formation of the lymphovascular embolus, a structure efficient at metastasis and resistant to chemotherapy through unknown cytoprotective mechanisms. Studies using a human xenograft model of IBC, MARY-X, indicate that the mechanism of E-cadherin overexpression is not transcriptional but related to altered protein trafficking. By real-time RT-PCR, E-cadherin transcript levels in MARY-X were 3- to 11-fold less than in other E-cadherin positive human breast carcinoma lines but the protein levels were 5- to 10-fold greater. In addition, several smaller E-cadherin protein fragments, e.g. 95 kDa, were present. To explain these observations, it was hypothesized that there may be altered protein trafficking. A real-time RT-PCR screen of candidate molecules generally known to regulate protein trafficking was conducted. The screen revealed 3.5- to 7-fold increased ExoC5 level and 10 to 20 fold decreased HRS and RAB7 levels, which was confirmed in human microdissected lymphovascular emboli. Since these alterations may only be correlative with E-cadherin overexpression, one of the molecules, Rab7, was selectively knocked down in MCF-7 cells. An increase in the full length 120 kDa E-cadherin and the de novo appearance of the 95 KD band were observed. These findings suggest that it is the altered E-cadherin trafficking that contributes to its oncogenic rather than suppressive role in IBC.


Asunto(s)
Cadherinas/metabolismo , Neoplasias Inflamatorias de la Mama/metabolismo , Neoplasias Inflamatorias de la Mama/patología , Animales , Cadherinas/biosíntesis , Cadherinas/genética , Línea Celular Tumoral , Femenino , Humanos , Neoplasias Inflamatorias de la Mama/genética , Vasos Linfáticos/metabolismo , Vasos Linfáticos/patología , Ratones , Ratones Desnudos , Ratones SCID , Células Neoplásicas Circulantes/metabolismo , Células Neoplásicas Circulantes/patología , Transporte de Proteínas , ARN Mensajero/biosíntesis , ARN Mensajero/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Esferoides Celulares/metabolismo , Esferoides Celulares/patología
7.
Bol. méd. Hosp. Infant. Méx ; 42(1): 21-30, ene. 1985. tab
Artículo en Español | LILACS | ID: lil-27780

RESUMEN

Con el propósito de conocer la evolución conductual de niños lactantes tratados por desnutrición proteinoenergética, una vez que éstos son reintegrados a su medio familiar, se investigaron 56 niños con edades comprendidas entre 6 y 29 meses, cinco de ellos durante 675 días. El grupo se dividió de acuerdo a la mediana global de desarrollo (67.1%) obtenida al egresar los niños de la institución en que fueron tratados. Entre aquellos que registraron más de 67.1%, el cociente medio se mantuvo, durante el lapso de estudio, entre 80 y 90%. Los niños que tuvieron cocientes por debajo de la mediana mostraron mayor incremento a partir del segundo año de su seguimiento, encontrándose al término de la investigación con un cociente medio dentro de lo normal. La conducta del lenguaje fue la que presentó mayor deterioro. Los hallazgos hacen suponer que en ciertos niños el retraso conductal generado por la desnutrición es reversible a largo plazo


Asunto(s)
Recién Nacido , Lactante , Preescolar , Humanos , Masculino , Femenino , Desarrollo Infantil , Desnutrición Proteico-Calórica/rehabilitación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA